Biotech Growth Trust (The) (LSE:BIOG) Notes Receivable: £0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:BIOG Biotech Growth Trust (The) PLC LSE:BIOG
39 GF Score
Price £15.90
! 2 Warning Signs
View Full Analysis

What is Biotech Growth Trust (The) Notes Receivable?

Biotech Growth Trust (The) LSE:BIOG -0.62% 39 Notes Receivable is £0.0 Mil as of Mar. 2026. GuruFocus rates LSE:BIOG with a GF Score™ of 39/100. The stock has 2 warning signs investors should review.

Biotech Growth Trust (The)'s Notes Receivable for the quarter that ended in Mar. 2026 was £0.0 Mil.

Biotech Growth Trust (The) Notes Receivable Related Terms

Biotech Growth Trust (The) Notes Receivable Historical Data

* Premium members only.

The historical data trend for Biotech Growth Trust (The)'s Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Growth Trust (The) Notes Receivable Chart

Biotech Growth Trust (The) Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Biotech Growth Trust (The) Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:BIOG
39GF Score
Biotech Growth Trust (The) PLC LSE:BIOG
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biotech Growth Trust (The) Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of £0.0 Mil mean?
Biotech Growth Trust (The) (LSE:BIOG) has a Notes Receivable of £0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Biotech Growth Trust (The) and its competitors.
Is Biotech Growth Trust (The)'s Notes Receivable too high?
Biotech Growth Trust (The)'s current Notes Receivable is £0.0 Mil. Overall, Biotech Growth Trust (The) has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s Notes Receivable compare to BLK and BX?
Biotech Growth Trust (The)'s Notes Receivable of £0.0 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Asset Management company?
A good Notes Receivable depends on the Asset Management industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Biotech Growth Trust (The) and its competitors. Biotech Growth Trust (The)'s current Notes Receivable is £0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current Notes Receivable of £0.0 Mil. The current Notes Receivable is £0.0 Mil. Biotech Growth Trust (The)'s overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current Notes Receivable is £0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotech Growth Trust (The) Business Description

Address 25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
39GF Score

Get the complete analysis for LSE:BIOG

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£15.90
Price